Supreme court strikes down patent on BRCA

Options
georgie1112
georgie1112 Member Posts: 282
edited June 2014 in Clinical Trials, Research News, Podcasts, and Study Results

Hope there will be less expensive testing soon. This is good news for research on breast cancer.

http://abcnews.go.com/Politics/supreme-court-strikes-brca-gene-patent/story?id=19392299#.Ubp_7pxstV0

· Share on FacebookShare on Twitter

Comments

  • voraciousreader
    voraciousreader Member Posts: 7,496
    edited June 2013

    Not so fast... Split decision and Myriad's stock went up 10% after stock market got wind of the decision. Many Supreme Court watchers believe the justices got it wrong...

    · Share on FacebookShare on Twitter
  • voraciousreader
    voraciousreader Member Posts: 7,496
    edited June 2013

    Stock market was confused by the Supreme Court's mixed decision. Going to have to wait and see where this decision settles. Based on the decision Myriad still owns many enforceable patents. Gina Kolata mentions the paradox of slowing down innovation if genes, specifically bacterial genes can't be patented. We might see prices of important genetic tests retreat due to competition, but we might also see less risks taken when it comes to investments in innovative research...

    · Share on FacebookShare on Twitter
  • georgie1112
    georgie1112 Member Posts: 282
    edited June 2013

    I think this article is better and is more optimistic: http://www.thenation.com/article/174789/supreme-court-strikes-down-human-gene-patents#axzz2W9cnbJ7A

    Hopefully companies will want to compete with Myriad's $4000 test as there is a profit to be made. The market's response is odd, but perhaps that engineered genes are patentable is good news for Myriad as they were expected to lose the patent on genes that are not manufactured.

    · Share on FacebookShare on Twitter

Categories